轉譯醫學之法制與政策分析

顏上詠

醫事法學

17卷1期（2010 / 06 / 01）

1 - 7

繁體中文

1. Dresser, Rebecca(2009).Vulnerability in Biomedical Research: First-in-Human Trial Participants: Not a Vulnerable Population, but Vulnerable Nonetheless.The Journal of Law, Medicine & Ethics.,Spring,6+7.
2. Girod, Jennifer,Drabiak, Katherine(2008).A Proposal for Comprehensive Biobank Research Laws to Promote Translational Medicine in Indiana.IND. Health L. REV.,5,218+230-31.
3. Mankoff, Stacey P.(2004).Lost in Translation: Obstacles to Translational Medicine.Journal of Translational Medicine,2(1),14.
4. Marchant, Gary E.(2007).Personalized Medicine and the Law.Arizona Attorney,44(12),12+16.
5. Ogilvie, David,Craig, Peter,Griffin, Simon,Macintyre, Sally,Wareham, Nicholas(2009).Journal of Translational MedicineJournal of Translational Medicine,BMC Public Health.
6. President''s Council of Adivosrs on Science and Technology(2008).,未出版
7. Rai , Arti K.(2008).Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery.Yale Journal of Health Policy, Law, and Ethics,Winter,1+24-32.
8. Zerhouni, Elias A.(2005).US Biomedical research-Basic, translational, and clinical science.JAMA,294,1352-54.

1. 陳介山(2013)。最新公司法修正簡評。嶺東通識教育研究學刊，5(1)，1-19。